Literature DB >> 30688997

Observational vs randomized: David vs Goliath for thromboprophylaxis in critically ill patients?

Julie Helms1,2,3, Julian Bion4, Audrey De Jong5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30688997     DOI： 10.1007/s00134-019-05541-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition.

Authors:  Russell E Glasgow; Edward Lichtenstein; Alfred C Marcus
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

3.  Implementation of a combo videolaryngoscope for intubation in critically ill patients: a before-after comparative study.

Authors:  Audrey De Jong; Noémie Clavieras; Matthieu Conseil; Yannael Coisel; Pierre-Henri Moury; Yvan Pouzeratte; Moussa Cisse; Fouad Belafia; Boris Jung; Gérald Chanques; Nicolas Molinari; Samir Jaber
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

4.  Effect of a quality improvement program on weaning from mechanical ventilation: a cluster randomized trial.

Authors:  Bo Zhu; Zhiqiang Li; Li Jiang; Bin Du; Qi Jiang; Meiping Wang; Ran Lou; Xiuming Xi
Journal:  Intensive Care Med       Date:  2015-07-09       Impact factor: 17.440

Review 5.  Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs.

Authors:  B R Flay
Journal:  Prev Med       Date:  1986-09       Impact factor: 4.018

6.  What's new in ICU in 2050: big data and machine learning.

Authors:  Sébastien Bailly; Geert Meyfroidt; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2017-12-26       Impact factor: 17.440

7.  A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.

Authors:  Henry T Stelfox; Rebecca Brundin-Mather; Andrea Soo; Jeanna Parsons Leigh; Daniel J Niven; Kirsten M Fiest; Christopher James Doig; Danny J Zuege; Barry Kushner; Fiona Clement; Sharon E Straus; Deborah J Cook; Sean M Bagshaw; Khara M Sauro
Journal:  Intensive Care Med       Date:  2019-02-01       Impact factor: 17.440

8.  Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.

Authors:  Jean-François Timsit; Marlieke E A de Kraker; Harriet Sommer; Emmanuel Weiss; Esther Bettiol; Martin Wolkewitz; Stavros Nikolakopoulos; David Wilson; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

9.  Decreasing severe pain and serious adverse events while moving intensive care unit patients: a prospective interventional study (the NURSE-DO project).

Authors:  Audrey de Jong; Nicolas Molinari; Sylvie de Lattre; Claudine Gniadek; Julie Carr; Mathieu Conseil; Marie-Pierre Susbielles; Boris Jung; Samir Jaber; Gérald Chanques
Journal:  Crit Care       Date:  2013-04-18       Impact factor: 9.097

10.  Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination.

Authors:  C Landelle; V Nocquet Boyer; M Abbas; E Genevois; N Abidi; S Naimo; R Raulais; L Bouchoud; F Boroli; H Terrisse; J-L Bosson; S Harbarth; J Pugin
Journal:  Intensive Care Med       Date:  2018-10-21       Impact factor: 17.440
View more
  1 in total

1.  COVID-19-related and non-COVID-related acute respiratory distress syndrome: two sides of the same coin?

Authors:  Audrey de Jong; Oriol Roca; Claude Guérin
Journal:  Intensive Care Med       Date:  2020-10-02       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.